Nexien Biopharma, Inc.

CIK 1625288 · operating company. SEC filings, financial statements, 10-K sections, 8-K items and insider trades for Nexien Biopharma, Inc..

Recent SEC filings

FiledFormAccession number
Sep 19, 202515-12G0001493152-25-014184
May 14, 202510-Q0001641172-25-010067
Feb 14, 202510-Q0001493152-25-006734
Nov 18, 202410-Q0001493152-24-046468
Nov 14, 2024NT 10-Q0001493152-24-045731
Oct 22, 202410-K0001493152-24-041978
Sep 30, 2024NT 10-K0001493152-24-038663
May 28, 202440001214659-24-010004
May 28, 202440001214659-24-010007
May 15, 202410-Q0001493152-24-019400
Feb 20, 202410-Q0001493152-24-007096
Feb 14, 2024NT 10-Q0001493152-24-006284
Nov 14, 202310-Q0001493152-23-041255
Nov 2, 202340001214659-23-014443
Nov 2, 202340001214659-23-014445
Sep 28, 202310-K0001493152-23-034480
Aug 3, 202340001214659-23-010690
Jul 31, 202340001214659-23-010399
Jul 31, 202340001214659-23-010505
May 17, 202310-Q0001493152-23-017925
May 15, 2023NT 10-Q0001493152-23-017228
Apr 19, 202340001214659-23-005656
Apr 19, 202340001214659-23-005671
Feb 8, 202310-Q0001493152-23-003903
Jan 18, 202340001214659-23-000783